Keng‐Chang Tsai

2.7k citations

103 papers · 2.2k indexed · h-index 27

Molecular Biology top 10%
Organic Chemistry top 5%
Computational Theory and Mathematics top 1%
Epidemiology top 10%
Infectious Diseases top 5%

Co-authors: An‐Suei Yang Chi‐Huey Wong Jim‐Min Fang Yih‐Shyun E. Cheng Shiyun Wang Tien‐Sheng Tseng Yu‐Ching Lee Minyong Li
Topics: Computational Drug Discovery Methods (18 papers)Monoclonal and Polyclonal Antibodies Research (14 papers)Influenza Virus Research Studies (10 papers)
Cited by: Computational Theory and Mathematics Organic Chemistry Molecular Biology
Journals: Journal of the American Chemical Society Journal of Biological Chemistry PLoS ONE
Partner nations: Taiwan United States China

In The Last Decade

Keng‐Chang Tsai

100 papers receiving 2.1k citations

Peers

Countries citing papers authored by Keng‐Chang Tsai

Since Specialization

Citations

This map shows the geographic impact of Keng‐Chang Tsai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keng‐Chang Tsai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keng‐Chang Tsai more than expected).

Fields of papers citing papers by Keng‐Chang Tsai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keng‐Chang Tsai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keng‐Chang Tsai. The network helps show where Keng‐Chang Tsai may publish in the future.

Co-authorship network of co-authors of Keng‐Chang Tsai

This figure shows the co-authorship network connecting the top 25 collaborators of Keng‐Chang Tsai. A scholar is included among the top collaborators of Keng‐Chang Tsai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keng‐Chang Tsai. Keng‐Chang Tsai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Broad-spectrum antiviral activity of Ganoderma microsporum immunomodulatory protein: Targeting glycoprotein gB to inhibit EBV and HSV-1 infections via viral fusion blockage 2025 ·International Journal of Biological Macromolecules ·(unknown),(unknown),Lin Wu,Yiyun Chen,(unknown),Tung‐Yi Lin,Yat‐Yuen Lim,Keng‐Chang Tsai,Ming‐Han Tsai	1
2	Discovery of a novel C2-functionalized chromen-4-one scaffold for the development of p38α MAPK signaling inhibitors to mitigate neutrophilic inflammatory responses 2025 ·Biochemical Pharmacology ·(unknown),Yi-Chen Lee,Shun‐Hua Chen,(unknown),(unknown),(unknown),Keng‐Chang Tsai,Po‐Jen Chen,Hsin‐Yi Hung	1
3	Discovery and biological evaluation of potent 2-trifluoromethyl acrylamide warhead-containing inhibitors of protein disulfide isomerase 2024 ·European Journal of Medicinal Chemistry ·(unknown),Keng‐Chang Tsai,Tingyu Wang,Tzu‐Yin Chen,(unknown),(unknown),Mei-Hsiang Lin,(unknown),Chin‐Chung Wu,Wei‐Jan Huang	0
4	Characterization of anti-EBNA-1 antibodies and exploration of their molecular mimicry potential in an EBV-infected Sjögren's syndrome patient 2024 ·Biochemical and Biophysical Research Communications ·(unknown),(unknown),Jiun-Han Lin,(unknown),(unknown),(unknown),(unknown),(unknown),Keng‐Chang Tsai,(unknown),Yu‐Ching Lee	1
5	Discovery of oral chemotherapeutic reversal agents for treating multidrug resistance cancer 2024 ·European Journal of Pharmacology ·(unknown),(unknown),Cheng‐Ping Yu,(unknown),(unknown),Keng‐Chang Tsai,Chen‐Hsi Chou,Chin‐Chuan Hung,Hsin‐Yi Hung	2
6	Design, structure–activity relationships, and enzyme kinetic studies of tricyclic and tetracyclic coumarin–based sulfamates as steroid sulfatase inhibitors 2023 ·Bioorganic Chemistry ·(unknown),I‐Chun Lin,(unknown),(unknown),(unknown),(unknown),Keng‐Chang Tsai,Yves S. Y. Hsieh,Mei‐Jou Chen,Mei‐Hsiang Lin,Pi‐Hui Liang	2
7	Novel (-)-arctigenin derivatives inhibit signal transducer and activator of transcription 3 phosphorylation and P-glycoprotein function resensitizing multidrug resistant cancer cells in vitro and in vivo 2023 ·European Journal of Pharmacology ·(unknown),Chan‐Yen Kuo,(unknown),(unknown),Keng‐Chang Tsai,Ping‐Chung Kuo,Jingwen Zeng,Chin‐Chuan Hung,Hsin‐Yi Hung	4
8	Design and synthesis of pyrazole derivatives against neutrophilic inflammation 2023 ·European Journal of Medicinal Chemistry ·(unknown),(unknown),Wei‐Chun Wang,(unknown),Keng‐Chang Tsai,Chen‐Hsi Chou,Tsong‐Long Hwang,Hsin‐Yi Hung	2
9	Effectiveness of anti-erythropoietin producing Hepatocellular receptor Type-A2 antibody in pancreatic cancer treatment 2023 ·Heliyon ·(unknown),Keng‐Chang Tsai,Tsai‐Yu Lin,(unknown),Shiow‐Lin Pan,Yu‐Ching Lee	2
10	Identification of the perpetrator imperatorin in Xin-yi-san-theophylline interaction: observed and predicted herb-drug interaction in rats 2023 ·Journal of Pharmacy and Pharmacology ·(unknown),(unknown),(unknown),Johnson Hsin-Chung Cheng,Li‐Ting Kao,Chung‐Kuang Lu,Keng‐Chang Tsai,I‐Jung Lee,Yune‐Fang Ueng	4
11	Design, Structure–Activity Relationships, And Enzyme Kinetic Studies of Tricyclic and Tetracyclic Coumarin–Based Sulfamates as Steroid Sulfatase Inhibitors 2023 ·SSRN Electronic Journal ·(unknown),I‐Chun Lin,(unknown),(unknown),(unknown),(unknown),Keng‐Chang Tsai,Yves S. Y. Hsieh,Mei‐Jou Chen,Mei‐Hsiang Lin,Pi‐Hui Liang	1
12	Pdia4 regulates β‐cell pathogenesis in diabetes: molecular mechanism and targeted therapy 2021 ·EMBO Molecular Medicine ·Tien‐Fen Kuo,(unknown),(unknown),Cicero Lee‐Tian Chang,(unknown),(unknown),(unknown),(unknown),Si‐Tse Jiang,Tuan‐Nan Wen,C.Y. Yang,Chung‐Yu Huang,Shu‐Huei Kao,Keng‐Chang Tsai,Greta Yang,Wen‐Chin Yang	13
13	Astragalus membranaceus–Derived Anti‐Programmed Death‐1 Monoclonal Antibodies with Immunomodulatory Therapeutic Effects against Tumors 2020 ·BioMed Research International ·(unknown),Keng‐Chang Tsai,Tsai‐Yu Lin,(unknown),(unknown),Wang-Chuan Chen,(unknown),Mei‐Kuang Lu,Chun-Tang Chiou,(unknown),Yun Yen,Shiow‐Lin Pan,Yu‐Ching Lee	18
14	Chicken-Derived Humanized Antibody Targeting a Novel Epitope F2pep of Fibroblast Growth Factor Receptor 2: Potential Cancer Therapeutic Agent 2019 ·ACS Omega ·Keng‐Chang Tsai,(unknown),(unknown),Tsai‐Yu Lin,(unknown),(unknown),(unknown),(unknown),Yu‐Ching Lee,Yun Yen	5
15	Characterizing the structure–function relationship reveals the mode of action of a novel antimicrobial peptide, P1, from jumper ant Myrmecia pilosula 2017 ·Molecular BioSystems ·Tien‐Sheng Tseng,Keng‐Chang Tsai,Chinpan Chen	11
16	Discovery of a potent cyclooxygenase-2 inhibitor, S4, through docking-based pharmacophore screening, in vivo and in vitro estimations 2016 ·Molecular BioSystems ·Tien‐Sheng Tseng,Show‐Mei Chuang,Nai-Wan Hsiao,Yi-Wen Chen,Yu‐Ching Lee,Chi‐Chen Lin,Cheng Huang,Keng‐Chang Tsai	7
17	Oseltamivir hydroxamate and acyl sulfonamide derivatives as influenza neuraminidase inhibitors 2014 ·Bioorganic & Medicinal Chemistry ·(unknown),Chun‐Lin Chen,Jim‐Min Fang,Keng‐Chang Tsai,Shiyun Wang,(unknown),Yih‐Shyun E. Cheng,Chi‐Huey Wong	17
18	Structure and Immunological Characterization of the Capsular Polysaccharide of a Pyrogenic Liver Abscess Caused by Klebsiella pneumoniae 2011 ·Journal of Biological Chemistry ·Feng‐Ling Yang,Yuliang Yang,Pei‐Chun Liao,Ju‐Ching Chou,Keng‐Chang Tsai,An‐Suei Yang,Fuu Sheu,Tzu‐Lung Lin,Pei‐Fang Hsieh,Jann‐Tay Wang,Kuo‐Feng Hua,Shih‐Hsiung Wu	58
19	How to Generate Reliable and Predictive CoMFA Models 2011 ·Current Medicinal Chemistry ·Lei Zhang,Keng‐Chang Tsai,Lüpei Du,Hao Fang,Minyong Li,Wenfang Xu	31
20	Effects of piroxicam-beta-cyclodextrin sachets on abnormal postural sway in patients with chronic low back pain 2008 ·Journal of Clinical Pharmacy and Therapeutics ·Shin‐Tsu Chang,Li–Chyong Chen,Chuan-Chia Chang,Hung‐Kuo Chu,Keng‐Chang Tsai	14

About Keng‐Chang Tsai

Keng‐Chang Tsai is a scholar working on Toxicology, Pharmacology and Computational Theory and Mathematics, having authored 103 papers that have together received 2.2k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (18 papers), Monoclonal and Polyclonal Antibodies Research (14 papers) and Influenza Virus Research Studies (10 papers). The work is most often cited by research in Computational Theory and Mathematics (406 citations), Organic Chemistry (555 citations) and Molecular Biology (975 citations). Keng‐Chang Tsai has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include An‐Suei Yang, Chi‐Huey Wong, Jim‐Min Fang, Yih‐Shyun E. Cheng, Shiyun Wang, Tien‐Sheng Tseng, Yu‐Ching Lee, Minyong Li, Nai‐Wan Hsiao and Thy‐Hou Lin. Their work appears in journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact